Literature DB >> 9358155

TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.

P R Bohjanen1, Y Liu, M A Garcia-Blanco.   

Abstract

The ability of the HIV-1 Tat protein to trans -activate HIV-1 transcription in vitro is specifically inhibited by a circular TAR RNA decoy. This inhibition is not overcome by adding an excess of Tat to the reaction but is partially overcome by adding Tat in combination with nuclear extract, suggesting that TAR RNA might function by interacting with a complex containing Tat and cellular factor(s). A cell-free transcription system involving immobilized DNA templates was used to further define the factor(s) that interact with TAR RNA. Preinitiation complexes formed in the presence or absence of Tat were purified on immobilized templates containing the HIV-1 promoter. After washing, nucleotides and radiolabelled UTP were added and transcription was measured. The presence of Tat during preinitiation complex formation resulted in an increase in the level of full-length HIV-1 transcripts. This Tat-activated increase in HIV-1 transcription was not inhibited by circular TAR decoys added during preinitiation complex formation but was inhibited by circular TAR decoys subsequently added during the transcription reaction. These results suggest that TAR decoys inhibit Tat-activated HIV-1 transcription after preinitiation complex formation, perhaps by interacting with components of transcription complexes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358155      PMCID: PMC147068          DOI: 10.1093/nar/25.22.4481

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region.

Authors:  R Gaynor; E Soultanakis; M Kuwabara; J Garcia; D S Sigman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

Authors:  J Berger; J Hauber; R Hauber; R Geiger; B R Cullen
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

4.  HIV-1 tat trans-activation requires the loop sequence within tar.

Authors:  S Feng; E C Holland
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

5.  Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  Separation and characterization of factors mediating accurate transcription by RNA polymerase II.

Authors:  M Samuels; A Fire; P A Sharp
Journal:  J Biol Chem       Date:  1982-12-10       Impact factor: 5.157

7.  In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.

Authors:  M G Toohey; K A Jones
Journal:  Genes Dev       Date:  1989-03       Impact factor: 11.361

8.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

9.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

10.  Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

Authors:  J A Garcia; D Harrich; E Soultanakis; F Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  9 in total

1.  In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Authors:  F Ducongé; J J Toulmé
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

Review 2.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

3.  Coupled in vitro synthesis and splicing of RNA polymerase II transcripts.

Authors:  S Ghosh; M A Garcia-Blanco
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

4.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

Review 5.  Novel cell and gene therapies for HIV.

Authors:  James A Hoxie; Carl H June
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

6.  Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy.

Authors:  C M Browning; L Cagnon; P D Good; J Rossi; D R Engelke; D M Markovitz
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  A hybrid neural network system for prediction and recognition of promoter regions in human genome.

Authors:  Chuan-Bo Chen; Tao Li
Journal:  J Zhejiang Univ Sci B       Date:  2005-05       Impact factor: 3.066

Review 8.  The role of exosomal transport of viral agents in persistent HIV pathogenesis.

Authors:  Benjamin J Patters; Santosh Kumar
Journal:  Retrovirology       Date:  2018-12-22       Impact factor: 4.602

9.  CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.

Authors:  Emmanuelle Wilhelm; Marie-Christine Doyle; Isaac Nzaramba; Alexandre Magdzinski; Nancy Dumais; Brendan Bell
Journal:  Retrovirology       Date:  2012-07-26       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.